Conclusion: Based on our analysis, patients using <20 g of kratom/d could be initiated on opioid agonist therapy with 4/1 mg-8/2 mg buprenorphine-naloxone/d, while patients using kratom doses >40 g/d could be initiated with 12/3 mg-16/4 mg of buprenorphine-naloxone/day.
PubMed 32858563 ↗Kratom
Also known as Mitragyna Speciosa
The short answer. People are split on Kratom — 46% of 335 say it helped. It is most often used for mood: 87% of 142 reports say that improved. There is a moderate body of research — 18 meta-analyses and 5 trials. The most common complaint is withdrawal.
From 568 mentions in total — the rest didn't say how it went and aren't counted.
What Kratom does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found. 18 meta-analyses on PubMed ↗ · 5 randomized trials ↗
Conclusion: Results inform clinicians working in the mental health and substance use fields, policy-makers, and researchers about the mental health effects of this plant.
PubMed 29248691 ↗Conclusion: We systematically review existing evidence and provide our own clinical cases. Clinicians need to be aware of the withdrawal symptomatology and implement a similar approach as for opioid withdrawal with long-term maintenance to prevent relapse.
PubMed 30614408 ↗Conclusion: This systematic review of the peer-reviewed literature regarding kratom in relation to maternal and infant outcomes resulted in analysis of six case reports of prenatal kratom exposure. Maternal and infant withdrawal from kratom exposure was described in each case, resulting in pharmacologic treatment for both mothers and infants.
PubMed 33589723 ↗14 human trials on ClinicalTrials.gov test Kratom — 4 completed, 5 recruiting now. See all on ClinicalTrials.gov ↗
- A Study of Mitragynine Formulations for Exercise-Induced Muscle Soreness in Healthy Adults · Delayed Onset Muscle Soreness (DOMS), Exercise-Induced Muscle Soreness · 2025
- Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience · Safety, Pharmacokinetics · 2024
- Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and Pharmacology · Chronic Pain, Fatigue · 2022
Reports to the FDA
Adverse-event reports about supplements containing it, submitted to the US FDA by consumers and doctors.
866 reports name a product containing Kratom (2008–2026); 579 involved hospitalization or worse. Most often reported:
- Death · 273
- Dependence · 258
- Toxicity to various agents · 132
- Withdrawal syndrome · 99
- Vomiting · 78
- Nausea · 77
A report doesn't prove the supplement caused the problem — many products contain several ingredients, and these counts can't tell you how often it happens. Source: FDA CAERS ↗ · raw reports (openFDA) ↗.
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Not a scheduled substance, but the DEA lists Kratom as a drug of concern. DEA fact sheet ↗
The FDA found Kratom as an undeclared ingredient in 3 products sold as supplements, most recently on 2026-05-28. FDA tainted-products database ↗
86 recalls of products named for Kratom. Most recent:
- 2025-11-19 · Class I: Product has the potential to be contaminated with Salmonella record ↗
- 2025-02-12 · Class I: Possible Salmonella contamination of affected product. record ↗
- 2023-12-20 · Class II: Finished product contains kratom (an unapproved food additive) and pH is over 5.0. The process authority letter classified product as acidified and pH… record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
NIH has funded 12 research projects with Kratom in the title, $16,134,764 in total (2018–2026). NIH RePORTER ↗
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Green or white Kratom powder. My productivity and overall mood have skyrocketed. I dose 4 grams once per day and it’s worked wonders.”
“Kratom/7Hydroxi makes me too sleepy and I feel dumb and slow on it.”
“kratom has been a Godsend and has really helped with getting me back on my feet. My preferred strain is Green Bali and found 2g to be my sweet spot in dose.”
“It keeps the depression, anxiety, suicidal and dark thoughts in check, but it also leaves my attention scattered, confused and makes me feel half-ADHD.”
Kratom compared
Other options for mood
Sources
- User reports: 568 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA recalls ↗
- FDA tainted-products database ↗
- US DEA ↗
- LiverTox (NIH) ↗
- NIH RePORTER ↗
- US Food and Drug Administration: CAERS adverse-event reports ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate